Triazolam
Overview
Triazolam is oral benzodiazepine used as a hypnotic agent in the short-term management of insomnia. its structure includes the addition of a triazole ring at the 1, 2 position. A substituent in the 7th position such as halogen or a nitro group is required for its sedative-hypnotic activity.The benzodiazipines are more effective and safer. Benzodiazepines can produce any level of CNS depression required including sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and coma. The action of these drugs is mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), potentiating the effects of GABA and increasing the inhibition of the ascending reticular activating system. Triazolam is often preferable to chlordiazepoxide, flurazepam, and prazepam in treating anxiety or insomnia, particularly in the elderly or patients with liver disease, because it has a relatively shorter half-life and does not generate active metabolites. It was approved by the FDA in 1982.
Categories
- 24 Psychotherapeutic drugs
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
No data regarding the contra indications of Triazolam is available.
Back to top
Back to top
Side Effects
Back to top
Dosage
Triazolam's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 250 to 125 mg | 190 (187.5) | 24 hourly | PO | At bed time. |
Paedriatic Dosage (20kg)
|
| | | | Not recommended in this age group |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Triazolam
Back to top
Previous Drug Generic - Next Drug Generic